US obesity rates decline for 1st time in more than a decade

Obesity Rates in the U.S. Drop for the First Time in a Decade, ‘Proliferation’ of Ozempic May Be a Reason
Study authors point to semaglutide medication and “behavior changes” as possible reasons for the drop in obesity rates in the U.S.
US obesity rates decline for first time in more than a decade
In a public health breakthrough, U.S. obesity rates have decreased for the first time in more than a decade, with new weight loss medications potentially playing a role in the turnaround, according to a new study.
Obesity dipped in U.S. adults last year for the first time in more than a decade
Obesity dipped slightly in U.S. adults last year, research found — the first time in more than a decade that the country has seen a downward trend. That might be due, in part, to the recent rise of blockbuster weight loss drugs like Ozempic, according to the study authors.
US obesity rates drop for 1st time in a decade, with possible help from weight loss medications
Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the South, where they had the highest dispensing rate of weight loss drugs known as GLP-1 receptor agonists, also saw a meaningful decline in obesity.
Obesity prevalence and BMI decrease in the US for the first time in a decade
Obesity prevalence in the US decreased in 2023, with significant drops in the South, highlighting the impact of GLP-1RA medications on health trends.
US obesity rates drop for the first time in a decade likely due to popular weight loss medications
Obesity rates in the United States have finally started to show a decline, heading in the right direction for the first time in a decade likely due to the popularity of weight loss drugs like Ozempic.
US For The First Time Sees A Drop In Obesity Rates
A new study reveals a slight drop in U.S. obesity rates, driven by weight loss drugs, lifestyle changes post-COVID, and regional trends. Experts caution that long-term impacts remain uncertain despite this encouraging sign.
Obesity giants will begin $80 bln M&A face-off
Eli Lilly and Novo Nordisk will kick off a massive shopping spree in 2025. The two obesity giants will be sitting on cash ...
Hosted on MSN16h
Endocrinologist Deserts; U.S. Obesity Declines; New Obesity Definition Coming Soon
Almost 70% of U.S. counties are "endocrinologist deserts," meaning they lack a single practicing endocrinologist, according ...
Pennsylvania Medicaid spent nearly $300 million on Wegovy and other anti-obesity drugs
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound and other anti-obesity drugs was third-highest in the ...
The American Journal of Managed Care13h
Top 5 Most-Read Obesity Articles in 2024
The most-read obesity articles of 2024 mostly focused on insurance coverage of weight loss medications and costs.
Cronkite News17h
Weighty problem: Oversized portions in restaurants contribute to obesity
As portion sizes continue to grow along with obesity rates, nutrition experts are looking at ways to encourage patrons to eat ...
Science Confirms: Eating a Balanced Breakfast Reduces Obesity and Heart Disease
Research indicates that a nutritious breakfast making up 20-30% of daily calories can reduce cardiovascular risk factors.
The Cool Down on MSN1d
Researchers make concerning connection between diesel exhaust and obesity — here's what you need to know
"Basically, what we're trying to show is there's potential influences that affect metabolic status and adipose tissue." ...
New study finds first US obesity decline in 10 years. Is Ozempic a leading factor?
Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...